We are live on
!
Find out more
UFF
USA Financial Formulas Portfolio holdings
AUM
$531M
1-Year Est. Return
28.6%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$61.7M
AUM Growth
–
Cap. Flow
+$61.1M
Cap. Flow
% of AUM
98.96%
Top 10 Holdings %
Top 10 Hldgs %
41.2%
Holding
424
New
424
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.45M |
| 2 |
Gilead Sciences
GILD
|
+$3.41M |
| 3 |
Ross Stores
ROST
|
+$3.25M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$3.18M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$3.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Energy | 9.7% |
| 5 | Consumer Staples | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
WaFd
WAFD
$2.77B
| $53.1K | 0.09% |
+1,762
| New | +$59.6K |
|
127
Renasant Corp
RNST
$3.96B
| $52.8K | 0.09% |
+1,727
| New | +$60.4K |
|
128
NBT Bancorp
NBTB
$2.75B
| $51.8K | 0.08% |
+1,538
| New | +$60.3K |
|
129
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $50.9K | 0.08% |
+620
| New | +$50.5K |
|
130
Enterprise Financial Services Corp
EFSC
$2.4B
| $50.1K | 0.08% |
+1,124
| New | +$57.5K |
|
131
iShares Core US Aggregate Bond ETF
AGG
$137B
| $50K | 0.08% |
+502
| New | +$49.6K |
|
132
Halozyme
HALO
$10.2B
| $49.5K | 0.08% |
+1,296
| New | +$60.8K |
|
133
T-Mobile US
TMUS
$193B
| $36.2K | 0.06% |
+250
| New | +$36.2K |
|
134
Cigna
CI
$72.7B
| $28.6K | 0.05% |
+112
| New | +$32.6K |
|
|
GTY
135
Getty Realty Corp
GTY
$2.06B
| $27.6K | 0.04% |
+766
| New | +$26.8K |
|
136
Haemonetics
HAE
$3.87B
| $26.9K | 0.04% |
+325
| New | +$26.3K |
|
|
HTO
137
H2O America
HTO
$2.59B
| $25.5K | 0.04% |
+335
| New | +$25.9K |
|
138
Humana
HUM
$44.1B
| $25.2K | 0.04% |
+52
| New | +$25.7K |
|
139
Lockheed Martin
LMT
$135B
| $25.1K | 0.04% |
+53
| New | +$24.9K |
|
140
Energizer
ENR
$1.48B
| $24.3K | 0.04% |
+699
| New | +$24.8K |
|
141
PBF Energy
PBF
$7.26B
| $23.5K | 0.04% |
+543
| New | +$22.9K |
|
142
Fabrinet
FN
$19.5B
| $23.5K | 0.04% |
+198
| New | +$24.6K |
|
143
Carpenter Technology
CRS
$27.7B
| $23.3K | 0.04% |
+520
| New | +$23.7K |
|
144
Northrop Grumman
NOC
$80.7B
| $23.1K | 0.04% |
+50
| New | +$23.2K |
|
145
ConocoPhillips
COP
$140B
| $22.8K | 0.04% |
+230
| New | +$25.2K |
|
146
EOG Resources
EOG
$71.4B
| $22.8K | 0.04% |
+199
| New | +$24.1K |
|
147
Visteon
VC
$2.75B
| $22.7K | 0.04% |
+145
| New | +$22.4K |
|
148
Eli Lilly
LLY
$1.06T
| $22.7K | 0.04% |
+66
| New | +$22.3K |
|
|
CHX
149
DELISTED
ChampionX
CHX
| $21.5K | 0.03% |
+794
| New | +$23.7K |
|
150
APA Corp
APA
$12.9B
| $21.4K | 0.03% |
+593
| New | +$23.8K |
|
Similar funds
EPA
TM
KI
PWS
SLC
LSCM
LIM
OC
USA Financial Formulas's Q1 2023 Portfolio in Review
Q1 2023 is the first quarter with a 13F filing on record for USA Financial Formulas, which disclosed 424 positions worth $61.7M. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Biogen: 12,485 shares worth $3.47M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Industrials and Consumer Discretionary.
- USA Financial Formulas's largest Q1 2023 buy was Biogen: 12,485 shares worth $3.47M.
- USA Financial Formulas's ten largest holdings make up 41% of its $61.7M portfolio in Q1 2023.
- USA Financial Formulas disclosed 424 positions in Q1 2023, its first 13F filing on record.
Based on USA Financial Formulas's 13F filing for Q1 2023, filed 27 Nov 2023.